Keynote Speakers 2024
Prof. Dr. med Ana Guerreiro Stücklin, MD PhD
Oncology, University Children's Hospital Zurich
Read more about Prof. Ana Guerreiro Stücklin’s research here:
Prof. Dr. Mitchell Levesque, PhD
Department of Dermatology, University Hospital Zurich
Read more about Prof. Dr. Mitch Levesque’s research here:
Prof. Dr. med. Chantal Pauli
Department of Pathology and Molecular Pathology, University Hospital Zurich
Read more about Prof. Dr. med. Chantal Pauli's research here:
Dr. med. Dr. sc. nat. Tobias Weiss
Department of Neurology, University Hospital Zurich
Read more about Dr. med. Dr. sc. nat. Tobias Weiss' research here:
Dr. med. vet Manuel Valiente, PhD
CNIO - Centro Nacional de Investigaciones Oncológicas
Read more about Dr. Valiente's research here:
Manuel Valiente is the Head of the Brain Metastasis Group at CNIO (2015-present). He investigates the biology of brain metastasis in order to challenge this unmet clinical need using his background in Neuroscience (PhD, Instituto de Neurociencias, 2005-2009) and Cancer Biology (Postdoc, MSKCC, 2010-2014).
Specifically, his laboratory studies novel brain metastasis mediators, characterizes the metastasis-associated microenvironment, designs better experimental models and explores novel methods to target brain metastasis, including the frequent impact on
brain activity. All these aims consider the brain environment as a critical component to understand the biology of this progression of cancer.
Dr. Valiente has co-founded the first National Network of Brain Metastasis (RENACER) in Spain, which is allowing his team to speed up the translation of laboratory findings to the clinic. His contributions to brain metastasis research have been recognized with the Banco Sabadell Award, ASPIRE Award, ERC CoG, EMBO YIP, CLIP Award, Beug Foundation’s Prize for Metastasis Research, Bristol-Myers Squibb-MRA Young Investigator Award among others.
He is the Chair of the Scientific Committee of the European Association of Neuro-Oncology (EANO), Board Member of the Metastasis Research Society (MRS) and ESMO faculty member (CNS Tumours faculty group).